Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type 2 diabetes

Diabetic Medicine

Volumn 18, Issue 7, 2001, Pages 584-588

  Taverna, M J ^a   Pacher, N ^a   Bruzzo, F ^a   Slama, G ^a   Selam, J L ^a,b  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

Author keywords

cell function; Insulin therapy; Secondary sulphonylurea failure; Type 2 diabetes

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA;

ADULT; ARTICLE; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; DIET THERAPY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREDICTION; TECHNIQUE; TREATMENT FAILURE;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CALIBRATION; DIABETES MELLITUS, TYPE 2; FEMALE; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SULFONYLUREA COMPOUNDS; TREATMENT FAILURE;

EID: 0034845814     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00534.x     Document Type: Article

References (17)

1. Insulin use in NIDDM
2. Insulin requirement in non-insulin-dependent diabetes mellitus: Relation to simple tests of islet B-cell function and insulin sensitivity
3. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: Methodological aspects and clinical applications
4. Insulin therapy in maturity-onset diabetes
5. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man
6. Understanding 'insulin resistance': Both glucose resistance and insulin resistance are required to model human diabetes
7. UKPDS 26: Sulphonylurea failure in non insulin-dependent diabetic patients over six years
8. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: The 10-year follow-up of the Belfast diet study
9. Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release
10. Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy
11. Correct homeostasis model assessment (HOMA) evaluation uses the computer program
12. The B-cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates
13. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
14. Comparison of tests of β-cell function across a range of glucose tolerance from normal to diabetes
15. Beta-cell function assessed by the hyperglycaemic clamp: Reproductibility compared with HOMA analysis from fasting values, and factors influencing variability
16. Glucose tolerance and B-cell function assessed by continuous infusion of glucose and oral glucose tolerance test
17. Practical evaluation of insulin sensitivity